Search

Accessing new eye therapies, protecting vision, improving patients' comfort, developing breaktrough treatments

Home

You are here : Home

Novagali Pharma - Accessing new eye Therapies

Novagali Pharma is an emerging ophthalmic pharmaceutical company that develops innovative products for all segments of the eye.

The company has developed a broad pipeline of innovative products addressing main ocular conditions as well as orphan diseases, thanks to its proprietary technology platforms Novasorb® and Eyeject®.

Press release

EVRY- April 24, 2008 - NOVAGALI PHARMA Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT® for Diabetic Macular Edema Read more

Launch of Cationorm®

Cationorm

EVRY- April 9, 2008 – Novagali Pharma announces the launch of Cationorm®

  • The innovative cationic emulsion for the treatment of dry eye symptoms
  • An optimal solution for patients
  • The first product developed from our pipeline to be marketed 
 Read more

Accessibility Focus

Our commitment to make our site accessible to anyone is based on the WCAG standards. Would you have any suggestion or request do not hesitate to contact us: Make a suggestion.

Choose your language